Search Within

Avni Mukund Desai

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Center for Pancreatic Cancer Research (6)
  2. Department of Medicine (6)
  3. Department of Pathology and Laboratory Medicine (6)
  4. Gastrointestinal Oncology Service (6)
  5. Genitourinary Oncology Service (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Geoffrey Ku (5)
  2. Yelena Janjigian (5)
  3. David Ilson (4)
  4. David Solit (4)
  5. Joanne Chou (4)
  6. Marinela Capanu (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2020 (1)
  5. 2019 (2)
Publications
  1. Clinical Cancer Research (1)
  2. Gastric Cancer (1)
  3. Journal of Clinical Oncology (1)
  4. Lancet Oncology (1)
  5. New England Journal of Medicine (1)
  6. The Oncologist (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Science, Inc. (1)
  4. Massachusetts Medical Society (1)
  5. Oxford University Press (1)
  6. Springer (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save